Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2025 to 2074 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
candidate tumor suppressor in ovarian cancer 2. [source:refseq;acc:nm\_080822]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4813.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5091.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2026\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartyl-trna synthetase (ec 6.1.1.12) (aspartate--trna ligase) (asprs). [source:swissprot;acc:p14868]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6766.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7155.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0575\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2027\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad9 homolog; cell cycle checkpoint control protein; rad9 homolog (s. pombe). [source:refseq;acc:nm\_004584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6218.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6575.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2028\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
54 kda nuclear rna- and dna-binding protein (p54(nrb)) (p54nrb) (55 kda nuclear protein) (nmt55) (non-pou domain-containing octamer- binding protein) (dna-binding p52/p100 complex, 52 kda subunit). [source:swissprot;acc:q15233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10243.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9686.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10241.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9685.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05742\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 2 (ec 2.1.1.43) (histone h3-k9 methyltransferase 2) (h3-k9-hmtase 2) (suppressor of variegation 3-9 homolog 2) (su(var)3-9 homolog 2). [source:swissprot;acc:q9h5i1]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5060.82\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5350.93\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05732\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 1 (eukaryotic translation initiation factor 2 alpha subunit) (eif-2-alpha) (eif- 2alpha) (eif-2a). [source:swissprot;acc:p05198]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2032\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 1 (ec 2.1.1.43) (histone h3-k9 methyltransferase 1) (h3-k9-hmtase 1) (suppressor of variegation 3-9 homolog 1) (su(var)3-9 homolog 1). [source:swissprot;acc:o43463]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2033\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein abstrakt homolog. [source:swissprot;acc:q9ujv9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6101.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6449.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2034\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
topoisomerase (dna) ii binding protein. [source:refseq;acc:nm\_007027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6920.71\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7315.59\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05706\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2035\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coenzyme a oxidase 1, peroxisomal (ec 1.3.3.6) (palmitoyl-coa oxidase) (aox). [source:swissprot;acc:q15067]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2036\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase f chain, mitochondrial (ec 3.6.3.14). [source:swissprot;acc:p56134]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2037\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2038\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 70 kda subunit (tafii-70) (tafii-80) (tafii80). [source:swissprot;acc:p49848]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7088.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7492.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2039\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l4 isoform a. [source:refseq;acc:nm\_015956]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3646.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3449.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05696\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2040\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho-gtpase-activating protein 8. [source:swissprot;acc:q9nsg0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6036.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6379.44\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05678\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2041\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho-gtpase-activating protein 1 (gtpase-activating protein rhoogap) (rho-related small gtpase protein activator) (cdc42 gtpase-activating protein) (p50-rhogap). [source:swissprot;acc:q07960]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2042\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin light chain 2 (klc 2). [source:swissprot;acc:q9h0b6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6379.38\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2043\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin heavy chain (ubiquitous kinesin heavy chain) (ukhc). [source:swissprot;acc:p33176]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6036.68\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6379.44\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2044\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin heavy chain isoform 5c (kinesin heavy chain neuron-specific 2). [source:swissprot;acc:o60282]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2045\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal kinesin heavy chain (nkhc) (kinesin heavy chain isoform 5a) (kinesin heavy chain neuron-specific 1). [source:swissprot;acc:q12840]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2046\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin light chain 1 (klc 1). [source:swissprot;acc:q07866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6379.48\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2047\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiia (factor a) (tfiiia). [source:swissprot;acc:q92664]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6036.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6379.44\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2048\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec3 (bm-012). [source:swissprot;acc:q9nv70]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2049\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin c2 isoform a; mammalian chromatin remodeling complex brg1-associated factor 170; chromatin remodeling complex baf170 subunit; swi3-like protein; swi/snf complex 170 kda subunit. [source:refseq;acc:nm\_003075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5634.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5953.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05648\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2050\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 2 beta 1 subunit (beta-adaptin) (plasma membrane adaptor ha2/ap2 adaptin beta subunit) (clathrin assembly protein complex 2 beta large chain) (ap105b). [source:swissprot;acc:p21851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5556.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5870.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05647\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2051\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l26. [source:swissprot;acc:q02877]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3601.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3409.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05646\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2052\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polybromo 1. [source:refseq;acc:nm\_018165]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5634.8\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5952.7\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05642\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2053\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin a5; sucrose nonfermenting-like 5. [source:refseq;acc:nm\_003601]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2054\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
possible global transcription activator snf2l4 (snf2-beta) (brg-1 protein) (mitotic growth and transcription activator) (brahma protein homolog 1). [source:swissprot;acc:p51532]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2055\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
possible global transcription activator snf2l1. [source:swissprot;acc:p28370]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2056\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbp-associated factor 172 (taf-172) (taf(ii)170). [source:swissprot;acc:o14981]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2057\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
possible global transcription activator snf2l2 (snf2-alpha). [source:swissprot;acc:p51531]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1b subunit (sigma-adaptin 1b) (adaptor protein complex ap-1 sigma-1b subunit) (golgi adaptor ha1/ap1 adaptin sigma-1b subunit) (clathrin assembly protein complex 1 sigma- 1b small chain) (sigma 1b subunit of ap-1 clathrin) (dc22). [source:swissprot;acc:p56377]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5552.69\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5865.84\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0564\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 gamma 1 subunit (gamma-adaptin) (adaptor protein complex ap-1 gamma-1 subunit) (golgi adaptor ha1/ap1 adaptin gamma-1 subunit) (clathrin assembly protein complex 1 gamma-1 large chain). [source:swissprot;acc:o43747]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1c subunit (sigma-adaptin 1c) (adaptor protein complex ap-1 sigma-1c subunit) (golgi adaptor ha1/ap1 adaptin sigma-1c subunit) (clathrin assembly protein complex 1 sigma- 1c small chain) (sigma 1c subunit of ap-1 clathrin). [source:swissprot;acc:q96pc3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 sigma 1a subunit (sigma-adaptin 1a) (adaptor protein complex ap-1 sigma-1a subunit) (golgi adaptor ha1/ap1 adaptin sigma-1a subunit) (clathrin assembly protein complex 1 sigma- 1a small chain) (clathrin coat assembly protein ap19) (ha1 19 kda subunit) (sigma 1a subunit of ap-1 clathrin). [source:swissprot;acc:q00382]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 gamma 2 subunit (gamma2-adaptin) (adaptor protein complex ap-1 gamma-2 subunit) (g2ad). [source:swissprot;acc:o75843]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5552.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5865.85\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin c1; mammalian chromatin remodeling complex brg1-associated factor 155; swi/snf complex 155 kda subunit; chromatin remodeling complex baf155 subunit. [source:refseq;acc:nm\_003074]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5634.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5952.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05635\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 1 beta 1 subunit (beta-adaptin 1) (adaptor protein complex ap-1 beta-1 subunit) (golgi adaptor ha1/ap1 adaptin beta subunit) (clathrin assembly protein complex 1 beta large chain). [source:swissprot;acc:q10567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5548.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5861.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05632\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l35. [source:swissprot;acc:p42766]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3602.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3410.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to glucosamine-phosphate n-acetyltransferase (hypothetical protein flj33258). [source:sptrembl;acc:q96ek6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5882.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6213.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05622\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15 (rig protein). [source:swissprot;acc:p11174]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3602.75\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3411.18\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05616\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l2. [source:refseq;acc:nm\_015950]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3411.17\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 16 kda polypeptide (ec 2.7.7.6) (rpa16). [source:swissprot;acc:q9y2s0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4632.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4892.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05613\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10178.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9638.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s26, mitochondrial precursor (mrp-s26) (mrp- s13). [source:swissprot;acc:q9byn8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6437.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6797.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05592\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of rudimentary homolog. [source:swissprot;acc:q14259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6083.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6423.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l14 (cag-isl 7). [source:swissprot;acc:p50914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3614.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3423.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/